These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 25114519

  • 1. Interleukin-6 and interleukin-8 blood levels' poor association with the severity and clinical profile of ex-smokers with COPD.
    de Moraes MR, da Costa AC, Corrêa Kde S, Junqueira-Kipnis AP, Rabahi MF.
    Int J Chron Obstruct Pulmon Dis; 2014; 9():735-43. PubMed ID: 25114519
    [Abstract] [Full Text] [Related]

  • 2. Comparison of inflammation biomarkers among chronic obstructive pulmonary disease groups: A cross sectional study.
    Yazici O, Gulen ST, Yenisey C, Eryilmaz U, Abas BI, Polatli M.
    Niger J Clin Pract; 2020 Jun; 23(6):817-824. PubMed ID: 32525117
    [Abstract] [Full Text] [Related]

  • 3. Skin condition and its relationship to systemic inflammation in chronic obstructive pulmonary disease.
    Majewski S, Pietrzak A, Tworek D, Szewczyk K, Kumor-Kisielewska A, Kurmanowska Z, Górski P, Zalewska-Janowska A, Piotrowski WJ.
    Int J Chron Obstruct Pulmon Dis; 2017 Jun; 12():2407-2415. PubMed ID: 28860735
    [Abstract] [Full Text] [Related]

  • 4. [Systemic inflammation among stable ex smokers with chronic obstructive pulmonary disease].
    Morales S A, Dreyse D J, Díaz P O, Saldías P F, Carrasco M, Lisboa B C.
    Rev Med Chil; 2010 Aug; 138(8):957-64. PubMed ID: 21140052
    [Abstract] [Full Text] [Related]

  • 5. Tumor necrosis factor receptor 2 as a possible marker of COPD in smokers and ex-smokers.
    Caram LMO, Ferrari R, Nogueira DL, Oliveira M, Francisqueti FV, Tanni SE, Corrêa CR, Godoy I.
    Int J Chron Obstruct Pulmon Dis; 2017 Aug; 12():2015-2021. PubMed ID: 28744116
    [Abstract] [Full Text] [Related]

  • 6. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
    Dreyse J, Díaz O, Repetto PB, Morales A, Saldías F, Lisboa C.
    Int J Chron Obstruct Pulmon Dis; 2015 Aug; 10():525-33. PubMed ID: 25792820
    [Abstract] [Full Text] [Related]

  • 7. Correlation between serum biomarkers and BODE index in patients with stable COPD.
    Liu SF, Chin CH, Wang CC, Lin MC.
    Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
    [Abstract] [Full Text] [Related]

  • 8. Airway inflammation in Japanese COPD patients compared with smoking and nonsmoking controls.
    Ishikawa N, Hattori N, Kohno N, Kobayashi A, Hayamizu T, Johnson M.
    Int J Chron Obstruct Pulmon Dis; 2015 Sep; 10():185-92. PubMed ID: 25670894
    [Abstract] [Full Text] [Related]

  • 9. Serum IL-1β and IL-17 levels in patients with COPD: associations with clinical parameters.
    Zou Y, Chen X, Liu J, Zhou DB, Kuang X, Xiao J, Yu Q, Lu X, Li W, Xie B, Chen Q.
    Int J Chron Obstruct Pulmon Dis; 2017 Sep; 12():1247-1254. PubMed ID: 28490868
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-6 and airflow limitation in chemical warfare patients with chronic obstructive pulmonary disease.
    Attaran D, Lari SM, Towhidi M, Marallu HG, Ayatollahi H, Khajehdaluee M, Ghanei M, Basiri R.
    Int J Chron Obstruct Pulmon Dis; 2010 Oct 05; 5():335-40. PubMed ID: 21037957
    [Abstract] [Full Text] [Related]

  • 11. Serum cytokine profiling and enrichment analysis reveal the involvement of immunological and inflammatory pathways in stable patients with chronic obstructive pulmonary disease.
    Bade G, Khan MA, Srivastava AK, Khare P, Solaiappan KK, Guleria R, Palaniyar N, Talwar A.
    Int J Chron Obstruct Pulmon Dis; 2014 Oct 05; 9():759-73. PubMed ID: 25125975
    [Abstract] [Full Text] [Related]

  • 12. Systemic cytokine signaling via IL-17 in smokers with obstructive pulmonary disease: a link to bacterial colonization?
    Andelid K, Tengvall S, Andersson A, Levänen B, Christenson K, Jirholt P, Åhrén C, Qvarfordt I, Ekberg-Jansson A, Lindén A.
    Int J Chron Obstruct Pulmon Dis; 2015 Oct 05; 10():689-702. PubMed ID: 25848245
    [Abstract] [Full Text] [Related]

  • 13. Altered serum levels of type I collagen turnover indicators accompanied by IL-6 and IL-8 release in stable COPD.
    Zeng YY, Hu WP, Zuo YH, Wang XR, Zhang J.
    Int J Chron Obstruct Pulmon Dis; 2019 Oct 05; 14():163-168. PubMed ID: 30655663
    [Abstract] [Full Text] [Related]

  • 14. Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.
    de Llano LP, Cosío BG, Iglesias A, de Las Cuevas N, Soler-Cataluña JJ, Izquierdo JL, López-Campos JL, Calero C, Plaza V, Miravitlles M, Torrego A, Martinez-Moragon E, Soriano JB, Viña AL, Bobolea I.
    Int J Chron Obstruct Pulmon Dis; 2018 Oct 05; 13():591-601. PubMed ID: 29483774
    [Abstract] [Full Text] [Related]

  • 15. The mediating role of cytokine IL-6 on the relationship of FEV₁ upon 6-minute walk distance in chronic obstructive pulmonary disease.
    Baldi S, Jose PE, Bruschi C, Pinna GD, Maestri R, Rezzani A, Bellinzona E, Fracchia C, Dacosto E, Crotti P, Montemartini S.
    Int J Chron Obstruct Pulmon Dis; 2014 Oct 05; 9():1091-9. PubMed ID: 25336940
    [Abstract] [Full Text] [Related]

  • 16. Increased serum levels of lipocalin-1 and -2 in patients with stable chronic obstructive pulmonary disease.
    Wang XR, Li YP, Gao S, Xia W, Gao K, Kong QH, Qi H, Wu L, Zhang J, Qu JM, Bai CX.
    Int J Chron Obstruct Pulmon Dis; 2014 Oct 05; 9():543-9. PubMed ID: 24920892
    [Abstract] [Full Text] [Related]

  • 17. Constant-load exercise decreases the serum concentration of myeloperoxidase in healthy smokers and smokers with COPD.
    Holz O, Roepcke S, Watz H, Tegtbur U, Lahu G, Hohlfeld JM.
    Int J Chron Obstruct Pulmon Dis; 2015 Oct 05; 10():1393-402. PubMed ID: 26229458
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.